Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 672 entries
View as:

Study to Evaluate the Safety and Efficacy of Vesatolimod in Antiretroviral Treated Human Immunodeficiency Virus (HIV-1) Infected Controllers

Phase: N/A Priority: Normal
NCT ID: NCT03060447 Org: User:
Start: 05/09/17 End: 02/13/20 Due: 02/13/21

Study to Evaluate Efficacy and Safety of Switching From TDF to TAF in Adults With Chronic Hepatitis B Who Are Virologically Suppressed

Phase: N/A Priority: Normal
NCT ID: NCT02979613 Org: User:
Start: 12/29/16 End: 01/30/20 Due: 01/30/21

A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of GS-9411 in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00951522 Org: User:
Start: 09/30/09 End: 09/30/09 Due: 09/30/10

Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B Infection

Phase: N/A Priority: Normal
NCT ID: NCT02258581 Org: User:
Start: 12/09/14 End: 08/14/17 Due: 08/14/18

A Study of Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C

Phase: N/A Priority: Normal
NCT ID: NCT01225380 Org: User:
Start: 10/31/10 End: 09/30/13 Due: 09/30/14

Tenofovir Disoproxil Fumarate (TDF) in HIV-1 Patients Who Have Never Taken Anti-HIV Drugs

Phase: N/A Priority: Normal
NCT ID: NCT00016588 Org: User:
Start: 05/31/01 End: - Due: -

Continued Access Study of Adefovir Dipivoxil (ADV) for Patients w/Chronic HBV Infection.

Phase: N/A Priority: Normal
NCT ID: NCT00158704 Org: User:
Start: 01/31/02 End: 01/31/05 Due: 01/31/06

Aztreonam for Inhalation (AI) in Patients With Cystic Fibrosis & P. Aeruginosa Infection

Phase: N/A Priority: Normal
NCT ID: NCT01055847 Org: User:
Start: 06/30/03 End: 09/30/04 Due: 09/30/05

Single Cohort, 2-Period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine 500 mg

Phase: N/A Priority: Normal
NCT ID: NCT01546558 Org: User:
Start: 02/29/12 End: 03/31/12 Due: 03/31/13

Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT02412098 Org: User:
Start: 03/19/15 End: 04/22/16 Due: 04/22/17

Tenofovir DF + Efavirenz (TDF+EFV) Versus Tenofovir DF + Efavirenz + Lamivudine (TDF+EFV+3TC) Maintenance Regimen in Virologically Controlled Patients: COOL Trial

Phase: N/A Priority: Normal
NCT ID: NCT00643968 Org: User:
Start: 03/31/03 End: 09/30/05 Due: 09/30/06

Selonsertib in Adults With Pulmonary Arterial Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT02234141 Org: User:
Start: 11/30/14 End: 12/31/16 Due: 12/31/17

Safety and Tolerability Study of MBX-2044 in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00422487 Org: User:
Start: 10/31/06 End: 09/30/07 Due: 09/30/08

Study of Magrolimab Versus Placebo in Combination With Venetoclax and Azacitidine in Participants With Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT05079230 Org: User:
Start: 07/07/22 End: 04/11/24 Due: 04/11/25

Phase I Study of the Safety, Tolerance, and Pharmacokinetics of 9-[2-(Bispivaloyloxymethyl)Phosphonylmethoxyethyl]Adenine (Bis-POM PMEA; Adefovir Dipivoxil) in HIV-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00002128 Org: User:
Start: - End: - Due: -

Study of the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults

Phase: N/A Priority: Normal
NCT ID: NCT00869557 Org: User:
Start: 04/30/09 End: 09/30/13 Due: 09/30/14

Long-Term Safety Study of GS-6624 in Adults With Idiopathic Pulmonary Fibrosis (IPF)

Phase: N/A Priority: Normal
NCT ID: NCT01759511 Org: User:
Start: 10/18/12 End: 02/19/16 Due: 02/19/17

A Phase 1a Trial Assessing the Safety, Tolerability, and Immunogenicity of GS-4774 (GI-13020) at Various Dose Levels and Regimens in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT01779505 Org: User:
Start: 01/31/13 End: 08/31/13 Due: 08/31/14

Study to Evaluate Switching From an E/C/F/TAF Fixed-Dose Combination (FDC) Regimen or a TDF Containing Regimen to B/F/TAF FDC in Human Immunodeficiency Virus-1 (HIV-1) Infected Participants Aged ≥ 65 Years

Phase: N/A Priority: Normal
NCT ID: NCT03405935 Org: User:
Start: 03/01/18 End: 05/29/20 Due: 05/29/21

Study to Evaluate the Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Abacavir/Dolutegravir/Lamivudine in Human Immunodeficiency Virus-1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults

Phase: N/A Priority: Normal
NCT ID: NCT02607930 Org: User:
Start: 11/13/15 End: 07/02/21 Due: 07/02/22

Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas

Phase: N/A Priority: Normal
NCT ID: NCT01732926 Org: User:
Start: 01/02/13 End: 05/17/16 Due: 05/17/17

Ambisome and Management of Culture-negative Neutropenic Fever Unresponsive to Antibiotics

Phase: N/A Priority: Normal
NCT ID: NCT00421187 Org: User:
Start: 03/31/07 End: 05/31/08 Due: 05/31/09

Study of TF2 Carcinoembryonic Antigen (CEA) Antibody in Patients With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01273402 Org: User:
Start: 02/28/11 End: 08/31/18 Due: 08/31/19

Study of Single Agent Idelalisib Followed by Idelalisib in Combination With Chemotherapy in Adults With Metastatic Pancreatic Ductal Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02468557 Org: User:
Start: 07/30/15 End: 04/27/16 Due: 04/27/17

Safety and Effectiveness Study of an Experimental Topical Ointment (GS-9191) for the Treatment of Genital Warts

Phase: N/A Priority: Normal
NCT ID: NCT00499967 Org: User:
Start: 08/31/07 End: 03/31/09 Due: 03/31/10